Guerbet SA (LON:0ELV)

Market Cap	81.97M -61.2%
Revenue (ttm)	696.74M -6.2%
Net Income	-94.51M
EPS	-7.49
Shares Out	n/a
PE Ratio	n/a
Forward PE	99.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4
Open	7.55
Previous Close	7.54
Day's Range	7.55 - 7.55
52-Week Range	7.48 - 19.58
Beta	0.98
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About Guerbet

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconnected solution; and Artirem, a gadoteric acid. The company also provides OptiStar Elite, a dual head contrast delivery system with an ultrasonic motor; ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1901
• Employees: 2,746
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ELV

Financial Performance

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 7, 2026

Data Sources Report a data error